AdaptHealth vs Viemed Healthcare
AHCO and VMD side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHCO and VMD compare
AdaptHealth is the larger company, worth 3.0 times as much as Viemed Healthcare ($1.0B against $345M).
Viemed Healthcare grew revenue faster over the last twelve months (25.2% versus 4.2% for AdaptHealth).
Viemed Healthcare keeps more of each dollar of sales as profit, with a net margin of 4.8% compared with −7.1% at AdaptHealth.
Viemed Healthcare scores higher on the StockData Score (17 against 6 for AdaptHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHCO | VMD |
|---|---|---|
| Size and price | ||
| Market cap | $1.0B | $345M |
| Share price | $7.53 | $9.07 |
| Change, 1 year | −18.1% | 41.9% |
| Change, 5 years | −65.1% | 73.4% |
| Beta (5Y) | −1.46 | −0.27 |
| Employees | 11K | 1,382 |
| StockData Score | ||
| Total score | 6 | 17 (better) |
| Valuation score | 3 | 4 (better) |
| Growth score | 0 | 5 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 3 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 25.2× |
| P/S | 0.3× (better) | 1.1× |
| P/B | 0.7× (better) | 2.4× |
| EV/EBITDA | 10.5× | 8.9× (better) |
| P/FCF | 10.5× (better) | 11.8× |
| PEG | – | 0.78 |
| FCF yield | 9.5% (better) | 8.5% |
| Fair value | $13.48 | $10.82 |
| Margin of safety | 44.1% (better) | 16.2% |
| Growth | ||
| Revenue growth (TTM) | 4.2% | 25.2% (better) |
| Revenue growth, 5Y average | 25.2% (better) | 15.5% |
| Net income growth (TTM) | −383% | 3.7% (better) |
| EPS growth (TTM) | −419% | 5.9% (better) |
| EPS growth, 5Y average | – | −13.9% |
| Profitability | ||
| Gross margin | 17.0% | 57.5% (better) |
| Operating margin | −4.5% | 7.5% (better) |
| Net margin | −7.1% | 4.8% (better) |
| FCF margin | 3.0% | 9.7% (better) |
| Return on equity | −15.4% | 10.2% (better) |
| Return on invested capital | −3.4% | 12.2% (better) |
| Financial health | ||
| Debt / equity | 1.37 | 0.05 (better) |
| Net debt / EBITDA | 6.79 (better) | −0.09 |
| Current ratio | 1.12 | 1.13 (better) |
| Altman Z-score | 0.61 | 6.18 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 5.3% |
| Shareholder yield | 0.00% | 5.3% (better) |
| Ownership | ||
| Held by institutions | 104% | 71.3% |
| Held by insiders | 14.7% | 15.4% |
| Insider net buying, 12 months | $49.1M (better) | −$1.6M |
| Short interest, % of float | 9.4% | 4.7% |
Go deeper
- AHCO stock overview
- AHCO income statement
- AHCO valuation and score
- VMD stock overview
- VMD income statement
- VMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.